GENIC CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,355 KRW | +2.44% |
|
+1.05% | -6.81% |
| May. 14 | Genic Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 20 | Genic Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 44,998 | 33,732 | 25,196 | 42,370 | 30,166 | 24,682 |
| Enterprise Value (EV) 1 | 62,503 | 50,489 | 42,739 | 45,389 | 35,320 | 30,066 |
| P/E ratio | -2.94 x | -2.82 x | -5.79 x | -9.78 x | -9.03 x | -5.6 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.65 x | 0.65 x | 0.6 x | 1.1 x | 0.96 x | 0.88 x |
| EV / Revenue | 0.91 x | 0.97 x | 1.01 x | 1.18 x | 1.12 x | 1.07 x |
| EV / EBITDA | -9.45 x | -54.2 x | 11.5 x | -27.9 x | -36.6 x | -13.5 x |
| EV / FCF | -7.06 x | 15.9 x | 12.7 x | 11.4 x | -26.1 x | 21.5 x |
| FCF Yield | -14.2% | 6.29% | 7.87% | 8.78% | -3.83% | 4.65% |
| Price to Book | 1.16 x | 1.24 x | 1.13 x | 2.2 x | 1.89 x | 2.14 x |
| Nbr of stocks (in thousands) | 6,849 | 6,856 | 6,856 | 6,856 | 6,856 | 6,856 |
| Reference price 2 | 6,570 | 4,920 | 3,675 | 6,180 | 4,400 | 3,600 |
| Announcement Date | 3/13/19 | 3/26/20 | 3/19/21 | 3/18/22 | 3/17/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 69,027 | 52,261 | 42,132 | 38,408 | 31,449 | 28,070 |
| EBITDA 1 | -6,617 | -932.3 | 3,716 | -1,627 | -966.2 | -2,220 |
| EBIT 1 | -11,410 | -5,194 | 691.3 | -3,940 | -2,850 | -4,021 |
| Operating Margin | -16.53% | -9.94% | 1.64% | -10.26% | -9.06% | -14.32% |
| Earnings before Tax (EBT) 1 | -13,109 | -11,959 | 30.89 | -4,199 | -3,340 | -4,411 |
| Net income 1 | -15,323 | -11,959 | -4,353 | -4,331 | -3,340 | -4,411 |
| Net margin | -22.2% | -22.88% | -10.33% | -11.28% | -10.62% | -15.71% |
| EPS 2 | -2,235 | -1,744 | -635.0 | -631.7 | -487.2 | -643.3 |
| Free Cash Flow 1 | -8,851 | 3,175 | 3,364 | 3,987 | -1,352 | 1,397 |
| FCF margin | -12.82% | 6.07% | 7.98% | 10.38% | -4.3% | 4.98% |
| FCF Conversion (EBITDA) | - | - | 90.53% | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/13/19 | 3/26/20 | 3/19/21 | 3/18/22 | 3/17/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 17,505 | 16,757 | 17,543 | 3,019 | 5,153 | 5,384 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -2.645 x | -17.97 x | 4.721 x | -1.855 x | -5.334 x | -2.425 x |
| Free Cash Flow 1 | -8,851 | 3,175 | 3,364 | 3,987 | -1,352 | 1,397 |
| ROE (net income / shareholders' equity) | -32.9% | -36.2% | 0.12% | -20.2% | -19% | -32.1% |
| ROA (Net income/ Total Assets) | -8.56% | -4.94% | 0.8% | -5.16% | -4.7% | -9.35% |
| Assets 1 | 179,083 | 242,173 | -545,339 | 83,984 | 71,045 | 47,176 |
| Book Value Per Share 2 | 5,680 | 3,959 | 3,257 | 2,815 | 2,325 | 1,682 |
| Cash Flow per Share 2 | 1,237 | 1,322 | 794.0 | 2,508 | 489.0 | 244.0 |
| Capex 1 | 3,060 | 831 | 769 | 649 | 1,423 | 841 |
| Capex / Sales | 4.43% | 1.59% | 1.83% | 1.69% | 4.53% | 3% |
| Announcement Date | 3/13/19 | 3/26/20 | 3/19/21 | 3/18/22 | 3/17/23 | 3/20/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -6.81% | 16.62M | |
| +16.71% | 141B | |
| +19.02% | 77.63B | |
| -6.91% | 69.73B | |
| -21.67% | 40.84B | |
| +8.03% | 35.06B | |
| -14.61% | 34.6B | |
| +9.76% | 18.57B | |
| +23.14% | 17.05B | |
| +9.23% | 12.91B |
- Stock Market
- Equities
- A123330 Stock
- Financials Genic Co., Ltd.
